WHO WE ARE
Arsenal Biosciences Inc. is a clinical-stage programmable cell therapy company engineering advanced CAR T-cell therapies for solid tumors. We seek a talented and experienced Sr. Research Associate II, Vivarium Operations (Contract) to work onsite based in our South San Francisco office.
ArsenalBio’s mission and purpose are very clear: defeat cancer. With our programmable and computationally driven approach, our team is engineering medicines to attack cancer’s inherent multifaceted nature and overcome the challenges of addressing solid tumors with cell therapy.
Driven by a collective of diverse experts across multi-scientific disciplines and clinical and manufacturing expertise, we are united in our purpose to develop the optimal medicines for improving patients’ lives.
This means you’ll have the opportunity to work with the best talent in the field of cell therapy and be part of ONE TEAM, which advances therapies for patients who need it most.
The Sr. Research Associate II, Vivarium Operations (Contract) focuses on conducting oncology animal models to evaluate programmable cell therapy while ensuring compliance with IACUC guidelines. Key responsibilities include animal handling, treatment administration, tumor burden assessment, and in vivo sample analysis using techniques like flow cytometry and bioluminescent imaging. The role also involves maintaining cancer and therapeutic cell lines, managing laboratory operations, and coordinating cross-functional research efforts. Accurate documentation and regulatory compliance are essential aspects of this position.
BENEFITS AND PAY
Our people-first culture cultivates a deep respect for humanity, not only in those we serve but also in one another. We take pride in being part of a company that values and celebrates diversity—in experiences, ideas, and interests. We are empowered in an environment that embraces unity and inclusivity, fostering a sense of belonging and mutual respect.
We provide powerful tools to empower our employees to take charge of their career paths and reach their full potential. At ArsenalBio, we believe in investing in our employees' well-being—both professionally and personally—because our people are our most valuable asset. Our essential team members bring exceptional expertise in molecular biology, immunology, pharmacology, protein chemistry, computational biology, automation, genome engineering, software, and other fields to turn the possibilities of tomorrow into the realities of today.
We are committed to hiring the best talent from diverse backgrounds. A diverse workforce engenders richness of thought, creativity and discovery. We invite individuals who embrace intellectual achievement to bring their unique personal and professional journeys and together we will build transformative cell therapies for cancer patients.
We are an equal opportunity employer and deeply value diversity within our company. We do not discriminate based on race, religion, color, national origin, gender, sexual orientation, age, marital status, veteran status, or disability.
The estimated pay for the preferred primary location of the San Francisco Bay area ranges from $47/hour - $57/hour. The pay offered may vary based on job-related knowledge, experience, education, etc. Beyond these considerations, we are committed to pay equity and consider the internal equity of our current employees when making any final offers.
To all recruitment agencies: ArsenalBio does not accept agency resumes. Please do not forward resumes to our jobs alias or to ArsenalBio employees. ArsenalBio is not responsible for any fees related to unsolicited resumes.
If an employer mentions a salary or salary range on their job, we display it as an "Employer Estimate". If a job has no salary data, Rise displays an estimate if available.
ArsenalBio is a privately-held clinical stage programmable cell therapy company engineering advanced CAR- T therapies for solid tumors. ArsenalBio’s mission is to develop efficacious and safe cellular therapies for patients with chronic diseases,...
23 jobsSubscribe to Rise newsletter